IT1397566B1 - Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso - Google Patents

Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Info

Publication number
IT1397566B1
IT1397566B1 ITRM2009A000270A ITRM20090270A IT1397566B1 IT 1397566 B1 IT1397566 B1 IT 1397566B1 IT RM2009A000270 A ITRM2009A000270 A IT RM2009A000270A IT RM20090270 A ITRM20090270 A IT RM20090270A IT 1397566 B1 IT1397566 B1 IT 1397566B1
Authority
IT
Italy
Prior art keywords
bacteriocines
manufacturer
food
pharmaceutical compositions
same
Prior art date
Application number
ITRM2009A000270A
Other languages
English (en)
Inventor
Luca Mogna
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITRM2009A000270A priority Critical patent/IT1397566B1/it
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to JP2012512470A priority patent/JP2012527884A/ja
Priority to EP10730508.8A priority patent/EP2435056B1/en
Priority to US13/322,795 priority patent/US9185927B2/en
Priority to PL10730508T priority patent/PL2435056T3/pl
Priority to PCT/IB2010/001290 priority patent/WO2010136891A1/en
Priority to ES10730508.8T priority patent/ES2534750T3/es
Priority to RU2011150659/10A priority patent/RU2547599C2/ru
Priority to AU2010252656A priority patent/AU2010252656B2/en
Priority to BRPI1011277A priority patent/BRPI1011277B8/pt
Priority to CN201080033176.7A priority patent/CN102458426B/zh
Publication of ITRM20090270A1 publication Critical patent/ITRM20090270A1/it
Application granted granted Critical
Publication of IT1397566B1 publication Critical patent/IT1397566B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/167—Pentosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ITRM2009A000270A 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso IT1397566B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
EP10730508.8A EP2435056B1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
US13/322,795 US9185927B2 (en) 2009-05-27 2010-05-27 Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
PL10730508T PL2435056T3 (pl) 2009-05-27 2010-05-27 Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych
JP2012512470A JP2012527884A (ja) 2009-05-27 2010-05-27 バクテリオシン産生ラクトバチルス・ペントーサスならびに食品および医薬組成物におけるその使用
PCT/IB2010/001290 WO2010136891A1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
ES10730508.8T ES2534750T3 (es) 2009-05-27 2010-05-27 Lactobacillus pentosus que produce bacteriocinas y uso del mismo en composiciones alimentarias y farmacéuticas
RU2011150659/10A RU2547599C2 (ru) 2009-05-27 2010-05-27 Бактериоцин-продуцирующий lactobacillus pentosus и его применение в пищевых и фармацевтических композициях
AU2010252656A AU2010252656B2 (en) 2009-05-27 2010-05-27 Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
BRPI1011277A BRPI1011277B8 (pt) 2009-05-27 2010-05-27 produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo
CN201080033176.7A CN102458426B (zh) 2009-05-27 2010-05-27 产生细菌素的戊糖乳杆菌及其在食品和药物组合物中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Publications (2)

Publication Number Publication Date
ITRM20090270A1 ITRM20090270A1 (it) 2010-11-28
IT1397566B1 true IT1397566B1 (it) 2013-01-16

Family

ID=41434751

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Country Status (11)

Country Link
US (1) US9185927B2 (it)
EP (1) EP2435056B1 (it)
JP (1) JP2012527884A (it)
CN (1) CN102458426B (it)
AU (1) AU2010252656B2 (it)
BR (1) BRPI1011277B8 (it)
ES (1) ES2534750T3 (it)
IT (1) IT1397566B1 (it)
PL (1) PL2435056T3 (it)
RU (1) RU2547599C2 (it)
WO (1) WO2010136891A1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
JP2013150599A (ja) * 2011-12-27 2013-08-08 Nihon Univ 抗菌物質生産菌と発酵菌を共培養する発酵法
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
JP5891337B2 (ja) 2013-04-17 2016-03-22 サントリーホールディングス株式会社 ラクトバチルス属菌含有組成物
JP5866115B2 (ja) * 2013-04-17 2016-02-17 サントリーホールディングス株式会社 ラクトバチルス属菌
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130792A1 (it) * 2013-05-14 2014-11-15 Mofin S R L Metodo per la prevenzione e/o riduzione dello sviluppo della listeria nell'industria casearia e prevenzione della listeriosi nell'uomo.
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
LT6142B (lt) 2013-05-15 2015-04-27 Uab "Biocentras" Sėklinių grūdų ir sėklų apdorojimo būdas
TWI643626B (zh) * 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
CN106754506B (zh) * 2016-12-21 2020-12-29 四川东坡中国泡菜产业技术研究院 一种低盐泡菜微生态添加剂及其制备方法
CN111567619B (zh) * 2020-06-22 2023-04-14 扬州大学 一种高品质火麻发酵乳的制作方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product

Also Published As

Publication number Publication date
EP2435056B1 (en) 2015-01-28
US20120164119A1 (en) 2012-06-28
WO2010136891A1 (en) 2010-12-02
AU2010252656A1 (en) 2012-01-12
RU2547599C2 (ru) 2015-04-10
AU2010252656B2 (en) 2015-02-05
ES2534750T3 (es) 2015-04-28
CN102458426B (zh) 2014-12-03
RU2011150659A (ru) 2013-07-10
JP2012527884A (ja) 2012-11-12
BRPI1011277A2 (pt) 2016-03-22
US9185927B2 (en) 2015-11-17
BRPI1011277B8 (pt) 2021-05-25
EP2435056A1 (en) 2012-04-04
BRPI1011277B1 (pt) 2021-03-23
CN102458426A (zh) 2012-05-16
PL2435056T3 (pl) 2015-06-30
ITRM20090270A1 (it) 2010-11-28

Similar Documents

Publication Publication Date Title
IT1397566B1 (it) Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
IL224288A (en) Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL222484A0 (en) Arginase inhibitor compounds, compositions comprising the same and uses thereof
IL222968A0 (en) Atr kinase inhibitor compounds, compositions comprising the same and uses thereof
IL220563A0 (en) Pteridinone compounds, compositions comprising the same and uses thereof
BRPI1005292A2 (pt) composição de decapagem e uso da composição
BR112012013148A2 (pt) formulação farmacêutica e uso
DK2657333T3 (da) Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf
IL226382A0 (en) Integrin agonist compounds, preparations containing them and their uses
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
IT1405432B1 (it) Preparazione alimentare funzionale ed uso relativo.
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
IL226270A0 (en) History of hydroxamic acid, preparations containing them and their uses
BRPI1005670A8 (pt) composições adjuvantes e processos de uso.
HK1182934A1 (zh) 種抗疲勞的組合物及其製劑和應用
IL223405B (en) Phosphoplatins, preparations containing them and their uses
IL219243A (en) History of 5-hydroxypyrimidine-4-carboxamide, preparations containing them and their uses
IL216462A0 (en) Nitrile derivatives, compositions comprising the same and uses thereof
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
IT1403156B1 (it) Inibitori di fosfatidilinositol 3-chinasi, relative composizioni ed usi.
BRPI1011417A2 (pt) uso de malonatos de benzilideno, preparação cosmética,e, malonatos de benzilideno.